Variant report
Variant | esv19136 |
---|---|
Chromosome Location | chr6:161811876-161814807 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs550807023 | chr6:161811898-161811899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs180924328 | chr6:161811905-161811906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576146691 | chr6:161811909-161811910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs552127230 | chr6:161811960-161811961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs529820687 | chr6:161812010-161812011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs546416620 | chr6:161812068-161812069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566224746 | chr6:161812087-161812088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs138867958 | chr6:161812102-161812103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs149407930 | chr6:161812122-161812123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs568787531 | chr6:161812136-161812137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs77763906 | chr6:161812143-161812144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs185853989 | chr6:161812171-161812172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73606919 | chr6:161812214-161812215 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs570384873 | chr6:161812240-161812241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs191490152 | chr6:161812301-161812302 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs554455028 | chr6:161812359-161812360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs62435891 | chr6:161812361-161812362 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs9346851 | chr6:161812419-161812420 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs144829055 | chr6:161812459-161812460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs547027786 | chr6:161812465-161812466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs576349098 | chr6:161812468-161812469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs76028111 | chr6:161812469-161812470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs547270236 | chr6:161812470-161812471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs397885650 | chr6:161812479-161812480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs561212725 | chr6:161812483-161812484 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs529981479 | chr6:161812520-161812521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs546379855 | chr6:161812568-161812569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs559873938 | chr6:161812612-161812613 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs11964284 | chr6:161812626-161812627 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs552221271 | chr6:161812676-161812677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs148595059 | chr6:161812721-161812722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs11967026 | chr6:161812728-161812729 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs182659961 | chr6:161812779-161812780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs142786879 | chr6:161812848-161812849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs185370725 | chr6:161812849-161812850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs534541541 | chr6:161812906-161812907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs147258109 | chr6:161812915-161812916 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs10455880 | chr6:161812932-161812933 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
39 | rs539669661 | chr6:161812969-161812970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs10455881 | chr6:161813005-161813006 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs576484849 | chr6:161813037-161813038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs542202912 | chr6:161813043-161813044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs531944241 | chr6:161813101-161813102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs190678285 | chr6:161813132-161813133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs572116190 | chr6:161813139-161813140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs182845590 | chr6:161813142-161813143 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs10455882 | chr6:161813159-161813160 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs560037987 | chr6:161813191-161813192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs10455883 | chr6:161813195-161813196 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs552122237 | chr6:161813204-161813205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 22241247 | CNVD |
Breast cancer | 16397240 | CNVD |
Atherosclerosis | 21956041 | CNVD |
Maculopathy | 20981449 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Astrocytoma | 16205629 | CNVD |
Parkinson disease | 17160897 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 22522925 | CNVD |
Schizophrenia | 20838587 | CNVD |
Early-onset parkinson disease | 21993715 | CNVD |
Glioblastoma | 18772890 | CNVD |
Pancreatic cancer | 20981101 | CNVD |
Autism | 21360662 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Intellectual disability | 22102821 | CNVD |
Parkinson disease | 0 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:161780600-161835800 | Weak transcription | Right Atrium | heart |
2 | chr6:161797600-161815000 | Weak transcription | Fetal Lung | lung |
3 | chr6:161811000-161815400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr6:161811200-161814600 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
5 | chr6:161811200-161815000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
6 | chr6:161811400-161814400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr6:161814400-161815000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr6:161814400-161815600 | Enhancers | Psoas Muscle | Psoas |
9 | chr6:161814400-161817800 | Enhancers | Skeletal Muscle Female | skeletal muscle |
10 | chr6:161814600-161815000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr6:161814600-161815600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
12 | chr6:161814800-161817800 | Enhancers | Brain Germinal Matrix | brain |